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Our approach to understanding the molecular pathways of homeobox genes and their role in feto-placental growth was based on the 119 following strategy: (i) identifying the spatio-temporal expression pattern of homeobox genes in human placental development that have 120 been identified as regulators of cell fate decisions during embryonic development; (ii) determining whether specific homeobox gene 121 expression levels are altered in placentae from FGR-affected pregnancies compared to placentae from gestation-matched 122 uncomplicated pregnancies; (iii) creating in vitro models using manipulated placental cultured cells that "mimic" homeobox gene 123 expression changes detected in FGR placentae (the manipulation involves the use of loss-or gain-of-function phenotypes by RNA 124 interference systems or gene overexpression plasmids); (iv) identifying the targets of homeobox genes using in vitro cell culture 125 models; and (v) identifying hormonal regulators of homeobox genes. Similar strategies have been proven successful in identifying 126 transcriptional control of endocrine functions during murine placental development [reviewed in 3]. Therefore, identification of the 127 homeobox target genes, their targets and hormonal regulators in specialised cell types of the human placenta could reveal important 128 molecular pathways responsible for feto-placental growth. Using the strategy described above, we undertook extensive analyses of 129 homeobox genes in placentae from FGR-affected and uncomplicated, gestation-matched control pregnancies. 130 131
Homeobox genes in the human placenta 132
Spatio-temporal expression patterns of homeobox genes in the placenta 133
We and others have identified the potential importance of homeobox genes DLX3, DLX4, GAX, ESX1L, HLX and TGIF-1 in the human 134 placenta [27, [30] [31] [32] [33] [34] . These homeobox genes are also expressed in the embryo and play pivotal roles in embryonic development [29, 135 35, 36] . More specifically, we demonstrated that homeobox gene HLX is expressed primarily in proliferating cytotrophoblast cell types 136 during early placental development [32] . We also determined the expression profile of homeobox gene DLX3 and TGIF-1 in the 137 human placenta [33, 34] . In first trimester and term placentae, DLX3 and TGIF-1 localised to the nuclei of villous cytotrophoblast 138 cells, the syncytiotrophoblast layer and proliferating extravillous trophoblast cells in the proximal region of the invading cell columns. 139
The following section summarises our current knowledge of homeobox gene regulation in human feto-placental development, 140 specifically in human trophoblast cells and reveals novel mechanisms behind trophoblast dysfunction, which is observed in placentae 141 from FGR pregnancies. 142 143
Homeobox gene expression levels are changed in idiopathic FGR placentae compared with gestation-matched controls 144
The pattern of normal human fetal growth is complex. Evidence reveals that maximal growth rate for length is detected in the second 145 trimester, whereas the maximal rate of weight gain is detected early in the third trimester [37] [38] [39] . Using a clinically well-defined 146 cohort of FGR pregnancies, we identified homeobox genes that showed differential gene expression in FGR-affected placentae 147 compared with gestation-matched control placentae. The cohort of FGR-affected pregnancies used for our studies was carefully 148 defined in clinical terms, representing the severe end of the spectrum for idiopathic FGR. Idiopathic FGR pregnancies were identified 149 with the general inclusion criterion of a birth weight less than the 10 th centile for gestation age, employing Australian growth charts. 
Creating in vitro models of placental cultured cells to "mimic" homeobox gene expression changes observed on FGR 160
Changes in the rate of trophoblast differentiation, proliferation and invasion are detected in FGR. We used well characterised, 161 transformed, trophoblast-derived cell lines, which model first trimester human villous and extravillous cytotrophoblast cells, and which 162 exhibit fundamental trophoblast cell properties including proliferation, differentiation, migration and invasion. The functional role of 163 homeobox genes was determined by changing homeobox gene expression to "mimic" the changes observed in FGR. We used the 164 techniques of gene inactivation or over-expression in these trophoblast-derived cell lines in vitro. For example, to assess the functional 165 role of decreased HLX levels observed in FGR, we decreased HLX expression levels in trophoblast-derived cell lines SGHPL4 and 166 HTR8-SV/neo using short-interference RNAs (siRNA) specific for HLX [44, 45] . The functional role of DLX3, which showed 167 increased expression in FGR, was determined by increasing the expression of DLX3 in trophoblast-derived cell line, BeWo, using a 168 
Conclusion 236
In this review, we have discussed the well-characterized roles of the homeobox genes in human placental development and function. 237
Here, we also propose that a differential response to fluctuating hormone signals may form a key controlling mechanism for homeobox 238 gene expression in the human placenta. By selectively modulating the activity of specific endocrine target genes, specific therapeutic 239 effects for the clinical management of FGR can be achieved. 240
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